Cerity Partners LLC Acquires 17,423 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Cerity Partners LLC lifted its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 227.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,093 shares of the company's stock after purchasing an additional 17,423 shares during the quarter. Cerity Partners LLC's holdings in Bath & Body Works were worth $801,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. CWM LLC lifted its holdings in shares of Bath & Body Works by 6.6% during the 2nd quarter. CWM LLC now owns 5,072 shares of the company's stock valued at $198,000 after buying an additional 314 shares during the period. Citizens & Northern Corp grew its stake in shares of Bath & Body Works by 1.7% during the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company's stock valued at $1,151,000 after purchasing an additional 487 shares during the period. Blue Trust Inc. increased its holdings in Bath & Body Works by 23.4% during the second quarter. Blue Trust Inc. now owns 2,767 shares of the company's stock valued at $108,000 after buying an additional 524 shares during the last quarter. GAMMA Investing LLC raised its holdings in Bath & Body Works by 34.4% in the 3rd quarter. GAMMA Investing LLC now owns 2,481 shares of the company's stock worth $79,000 after purchasing an additional 635 shares during the period. Finally, Horizon Bancorp Inc. IN grew its holdings in Bath & Body Works by 19.6% during the second quarter. Horizon Bancorp Inc. IN now owns 4,232 shares of the company's stock valued at $165,000 after purchasing an additional 695 shares during the period. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Trading Down 0.5 %

Shares of NYSE BBWI traded down $0.18 during trading hours on Friday, hitting $36.60. 5,623,111 shares of the company traded hands, compared to its average volume of 4,013,351. The company's 50 day moving average price is $31.72 and its 200 day moving average price is $35.24. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The stock has a market capitalization of $7.93 billion, a price-to-earnings ratio of 8.97, a price-to-earnings-growth ratio of 1.38 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the prior year, the firm posted $0.48 earnings per share. The business's revenue for the quarter was up 3.1% on a year-over-year basis. Equities analysts anticipate that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be issued a $0.20 dividend. The ex-dividend date is Friday, November 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.19%. Bath & Body Works's payout ratio is 19.51%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on BBWI shares. Piper Sandler lifted their price objective on Bath & Body Works from $35.00 to $36.00 and gave the company a "neutral" rating in a research report on Tuesday, November 26th. Raymond James lowered their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an "outperform" rating on the stock in a report on Thursday, August 29th. Robert W. Baird reduced their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating for the company in a research note on Thursday, August 29th. UBS Group lowered their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a "neutral" rating on the stock in a research note on Thursday, August 29th. Finally, Bank of America cut their price target on Bath & Body Works from $54.00 to $45.00 and set a "buy" rating for the company in a research note on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works currently has an average rating of "Moderate Buy" and a consensus price target of $41.88.

Insider Transactions at Bath & Body Works

In related news, CEO Gina Boswell acquired 6,000 shares of the firm's stock in a transaction that occurred on Wednesday, October 9th. The stock was bought at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares of the company's stock, valued at $7,202,134.68. This represents a 2.53 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.27% of the company's stock.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.